GlassScriptPhysician profile
Jeffrey L Shakin
NPI 1245343532
$2,981.52
in general payments reported to CMS, 2019-2025
18 companies · $440 in 2025
The $440 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $551 · 2020: $46.43 · 2021: $217 · 2022: $461 · 2023: $667 · 2024: $599 · 2025: $440.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,707.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,706.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $534.82 | 2019-2025 | Vabysmo |
| Regeneron Healthcare Solutions, INC. | $419.70 | 2019-2025 | Eylea Hd |
| Apellis Pharmaceuticals, INC. | $329.20 | 2022-2024 | Syfovre |
| Bausch & Lomb Americas INC. | $275.00 | 2024-2025 | Envista Mx60 Iol, Miebo, Xiidra |
| Glaukos Corporation | $232.30 | 2019-2025 | Idosetr |
| Abbvie INC. | $169.37 | 2022-2025 | |
| Allergan, INC. | $149.96 | 2019-2021 | |
| Coherus Oncology, INC. | $137.51 | 2023 | |
| Omeros Corporation | $124.90 | 2019 | |
| Sun Pharmaceutical Industries INC. | $122.11 | 2023 | Cequa |
| Kala Pharmaceuticals, INC. | $119.32 | 2019 | |
| Carl Zeiss Meditec USA, INC. | $109.60 | 2021 | |
| Alcon Vision LLC | $106.49 | 2022 | |
| Astellas Pharma US INC | $56.66 | 2024 | Izervay |
| Novartis Pharmaceuticals Corporation | $29.08 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sandoz INC. | $27.82 | 2024 | Cimerli |
| Mallinckrodt Hospital Products INC. | $27.74 | 2020 | |
| Alimera Sciences, INC. | $9.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Shakin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.